SEC Tracker
Get the app

Aspen Neuroscience ASPE

Aspen Neuroscience completed its IPO

Item 5.03 Amends charter or bylaws, Item 8.01 Other events

Form
8-K
Filed
Importance
Notable
  1. IPO of 9,375,000 shares at $15.00 per share
  2. Gross proceeds of $140.6 million
  3. Amended certificate of incorporation and bylaws effective

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Aspen Neuroscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX